Lexaria Bioscience Corp - Asset Resilience Ratio
Lexaria Bioscience Corp (LEXXW) has an Asset Resilience Ratio of 2.37% as of November 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Lexaria Bioscience Corp debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Lexaria Bioscience Corp's Asset Resilience Ratio has changed over time. See net assets of Lexaria Bioscience Corp for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Lexaria Bioscience Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lexaria Bioscience Corp market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $143.27K | 2.37% |
| Total Liquid Assets | $143.27K | 2.37% |
Asset Resilience Insights
- Limited Liquidity: Lexaria Bioscience Corp maintains only 2.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Lexaria Bioscience Corp Industry Peers by Asset Resilience Ratio
Compare Lexaria Bioscience Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
Annual Asset Resilience Ratio for Lexaria Bioscience Corp (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Lexaria Bioscience Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-08-31 | 3.96% | $165.36K | $4.18 Million | +3.33pp |
| 2024-08-31 | 0.63% | $55.81K | $8.87 Million | -3.44pp |
| 2023-08-31 | 4.07% | $125.64K | $3.08 Million | -0.36pp |
| 2022-08-31 | 4.43% | $347.33K | $7.83 Million | -1.85pp |
| 2021-08-31 | 6.29% | $833.84K | $13.27 Million | +5.60pp |
| 2020-08-31 | 0.68% | $19.32K | $2.83 Million | -1.72pp |
| 2019-08-31 | 2.40% | $64.21K | $2.68 Million | +1.98pp |
| 2018-08-31 | 0.42% | $10.15K | $2.43 Million | -- |
About Lexaria Bioscience Corp
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall … Read more